Skip to main content
. Author manuscript; available in PMC: 2022 Feb 1.
Published in final edited form as: Transl Stroke Res. 2020 Mar 20;12(1):112–124. doi: 10.1007/s12975-020-00807-y

Fig.5. CD133+Exo treatment significantly decreases cardiac oxidative stress in T2DM-stroke mice.

Fig.5

CD133+Exo treatment in T2DM-stroke mice significantly decreases oxidative stress marker a) NADPH oxidase-2 (NOX2) expression and b) 4-Hydroxynonenal (4-HNE) expression compared to PBS treated T2DM-stroke mice. T2DM-stroke+PBS: n=7; T2DM-stroke+CD133+Exo: n=8.